Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Sparing Effect on Propofol and Remifentanil
NCT00921284Phase 3Completed
- Sponsor
- Hôpital Foch
- Start
- Jun 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Anesthesia, sponsored by Hôpital Foch. Primary endpoint: Administered dose of propofol. Started Jun 2009; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT00921284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00921284.